Pharmaceutical companies in the United States by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 44 pharmaceutical companies in the United States ranked by one-year price change, at +387%, ahead of Spyre Therapeutics (+302%) and Oruka Therapeutics (+233%). Figures as of 20 Nov 2026, 12:11 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- Erasca+387%
- Median
- +22.1%
- Combined market value
- CZK 83.29T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +387% | CZK 111.3B | CZK 317.03 | 3.34% up | 387% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +302% | CZK 206.7B | CZK 2,176.64 | 3.77% down | 302% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +233% | CZK 147.5B | CZK 2,175.30 | 1.91% up | 233% up | ||
| 4 | VeradermicsMANE · Health Care | +230% | CZK 117B | CZK 2,773.25 | 0.38% down | 230% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +176% | CZK 90B | CZK 657.25 | 1.24% up | 176% up | ||
| 6 | Dianthus TherapeuticsDNTH · Health Care | +105% | CZK 106.5B | CZK 1,891.27 | 1.01% up | 105% up | ||
| 7 | TG TherapeuticsTGTX · Health Care | +103% | CZK 218.6B | CZK 1,446.49 | 1.88% down | 103% up | ||
| 8 | ViatrisVTRS · Health Care | +90.1% | CZK 508.1B | CZK 443.22 | 1.97% down | 90% up | ||
| 9 | Praxis Precision MedicinesPRAX · Health Care | +83.1% | CZK 193.7B | CZK 6,931.45 | 1.87% up | 83% up | ||
| 10 | Edgewise TherapeuticsEWTX · Health Care | +81.6% | CZK 100.5B | CZK 917.88 | 0.48% down | 82% up | ||
| 11 | Amneal PharmaceuticalsAMRX · Health Care | +79.0% | CZK 166.2B | CZK 476.89 | 2.24% down | 79% up | ||
| 12 | Royalty PharmaRPRX · Health Care | +74.0% | CZK 868.1B | CZK 1,509.80 | 1.38% down | 74% up | ||
| 13 | Protagonist TherapeuticsPTGX · Health Care | +45.2% | CZK 180.5B | CZK 2,765.00 | 2.47% down | 45% up | ||
| 14 | Ligand PharmaceuticalsLGND · Health Care | +44.0% | CZK 128B | CZK 6,397.27 | 3.94% down | 44% up | ||
| 15 | Travere TherapeuticsTVTX · Health Care | +39.2% | CZK 103.4B | CZK 1,076.84 | 3.86% down | 39% up | ||
| 16 | Merck & CoMRK · Health Care | +35.9% | CZK 7.3T | CZK 2,960.97 | 3.61% down | 36% up | ||
| 17 | Mirum PharmaceuticalsMIRM · Health Care | +34.6% | CZK 139B | CZK 2,129.38 | 3.27% up | 35% up | ||
| 18 | Johnson & JohnsonJNJ · Health Care | +31.0% | CZK 14.34T | CZK 5,955.83 | 2.04% down | 31% up | ||
| 19 | Eli LillyLLY · Health Care | +27.5% | CZK 26.83T | CZK 30,122.95 | 2.29% down | 28% up | ||
| 20 | Bristol-Myers SquibbBMY · Health Care | +26.1% | CZK 2.66T | CZK 1,300.68 | 2.05% down | 26% up | ||
| 21 | Belite BioBLTE · Health Care | +25.3% | CZK 136.7B | CZK 3,366.96 | 3.33% down | 25% up | ||
| 22 | Regeneron PharmaceuticalsREGN · Health Care | +22.2% | CZK 2.13T | CZK 20,585.68 | 2.35% down | 22% up | ||
| 23 | Vertex PharmaceuticalsVRTX · Health Care | +22.0% | CZK 2.94T | CZK 11,608.01 | 2.94% down | 22% up | ||
| 24 | AbbVieABBV · Health Care | +20.0% | CZK 11.17T | CZK 6,321.47 | 0.86% down | 20% up | ||
| 25 | Elanco Animal HealthELAN · Health Care | +18.2% | CZK 293B | CZK 586.13 | 1.54% down | 18% up | ||
| 26 | United TherapeuticsUTHR · Health Care | +17.7% | CZK 530.9B | CZK 12,465.02 | 3.16% down | 18% up | ||
| 27 | Rhythm PharmaceuticalsRYTM · Health Care | +14.8% | CZK 180.5B | CZK 2,604.03 | 1.88% down | 15% up | ||
| 28 | BridgeBio PharmaBBIO · Health Care | +14.8% | CZK 339.5B | CZK 1,743.01 | 0.22% up | 15% up | ||
| 29 | BioMarin PharmaceuticalBMRN · Health Care | +12.3% | CZK 265.2B | CZK 1,369.35 | 0.02% down | 12% up | ||
| 30 | PfizerPFE · Health Care | +9.98% | CZK 3.5T | CZK 614.00 | 1.85% down | 10% up | ||
| 31 | Arrowhead PharmaceuticalsARWR · Health Care | +7.91% | CZK 137.6B | CZK 973.17 | 1.25% up | 8% up | ||
| 32 | Axsome TherapeuticsAXSM · Health Care | -9.21% | CZK 159.1B | CZK 3,024.96 | 1.25% up | 9% down | ||
| 33 | Corcept TherapeuticsCORT · Health Care | -15.9% | CZK 158.6B | CZK 1,448.72 | 4.15% down | 16% down | ||
| 34 | Abbott LaboratoriesABT · Health Care | -18.9% | CZK 4.01T | CZK 2,315.76 | 0.58% down | 19% down | ||
| 35 | CytokineticsCYTK · Health Care | -21.4% | CZK 159.8B | CZK 1,147.29 | 0.27% up | 21% down | ||
| 36 | Cogent BiosciencesCOGT · Health Care | -24.5% | CZK 107.6B | CZK 618.46 | 0.25% down | 25% down | ||
| 37 | PTC TherapeuticsPTCT · Health Care | -25.7% | CZK 108.6B | CZK 1,300.34 | 3.16% down | 26% down | ||
| 38 | InsmedINSM · Health Care | -27.3% | CZK 706.6B | CZK 3,220.71 | 20.58% up | 27% down | ||
| 39 | Madrigal PharmaceuticalsMDGL · Health Care | -27.6% | CZK 205.5B | CZK 8,845.24 | 0.34% down | 28% down | ||
| 40 | ZoetisZTS · Health Care | -33.8% | CZK 731.9B | CZK 1,801.20 | 5.59% down | 34% down | ||
| 41 | Summit TherapeuticsSMMT · Health Care | -34.7% | CZK 188.5B | CZK 235.66 | 0.67% up | 35% down | ||
| 42 | Legend BiotechLEGN · Health Care | -42.8% | CZK 69.6B | CZK 358.95 | 0.92% down | 43% down | ||
| 43 | Ionis PharmaceuticalsIONS · Health Care | -64.2% | CZK 101.1B | CZK 606.86 | 0.62% down | 64% down | ||
| 44 | Alnylam PharmaceuticalsALNY · Health Care | -66.1% | CZK 441.4B | CZK 3,295.62 | 1.06% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2948 CZK).
Questions and answers
Which pharmaceutical companies in the United States rank first by one-year price change?
Erasca (+387%), Spyre Therapeutics (+302%) and Oruka Therapeutics (+233%) are the top three of the 44 pharmaceutical companies in the United States ranked by one-year price change as of 20 Nov 2026, 12:11 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by one-year price change.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by one-year price change have a combined market value of CZK 83.29T as of 20 Nov 2026, 12:11 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceutical companies in the United States by one-year price change”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.